Literature DB >> 17488249

Pharmacologically mediated colon ischemia.

David J Hass1, Patricia Kozuch, Lawrence J Brandt.   

Abstract

Colon ischemia (CI) is the most common form of ischemic injury of the gastrointestinal tract. Determining the precise incidence of CI is a challenging task, because of its often brief, mild nature, and frequent spontaneous resolution, as well as its misdiagnosis as other diseases. While many underlying disease conditions may predispose patients to CI, an important and possibly overlooked etiology is that of pharmacologically induced alterations of colonic blood flow. This review details the pharmacologic agents known to be associated with CI; when possible, their mechanisms of action are described. The aim of this paper is to highlight this often unrecognized cause of CI, thereby helping physicians to be aware of the association, to recognize its occurrence promptly, and to possibly reduce morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488249     DOI: 10.1111/j.1572-0241.2007.01260.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  16 in total

1.  Irritable bowel syndrome and ischemic colitis: evidence supporting the increased use of alosetron.

Authors:  Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program.

Authors:  Kenneth Tong; Jean Paul Nicandro; Reshma Shringarpure; Emil Chuang; Lin Chang
Journal:  Therap Adv Gastroenterol       Date:  2013-09       Impact factor: 4.409

3.  ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI).

Authors:  Lawrence J Brandt; Paul Feuerstadt; George F Longstreth; Scott J Boley
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

Review 4.  Ischaemic colitis: practical challenges and evidence-based recommendations for management.

Authors:  Alex Hung; Tom Calderbank; Mark A Samaan; Andrew A Plumb; George Webster
Journal:  Frontline Gastroenterol       Date:  2019-12-13

5.  Acute vascular insufficiency of intestine: incidence highest in summer, outcomes worst in winter.

Authors:  Asad Jehangir; Rashmi Dhital; Anam Qureshi; Eugene P York
Journal:  Int J Colorectal Dis       Date:  2019-11-09       Impact factor: 2.571

Review 6.  The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies.

Authors:  James H Lewis
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

7.  Ischemic colitis after mesotherapy combined with anti-obesity medications.

Authors:  Jong Bin Kim; Won Moon; Seun Ja Park; Moo In Park; Kyu-Jong Kim; Jae Nam Lee; Seong Joo Kang; Lee La Jang; Hee Kyung Chang
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 8.  Ischemic colitis: clinical practice in diagnosis and treatment.

Authors:  Angeliki Theodoropoulou; Ioannis-E Koutroubakis
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

Review 9.  Update on Colon Ischemia: Recent Insights and Advances.

Authors:  Paul Feuerstadt; Lawrence J Brandt
Journal:  Curr Gastroenterol Rep       Date:  2015-12

10.  Update on the Diagnosis and Management of Colon Ischemia.

Authors:  Ann D Flynn; John F Valentine
Journal:  Curr Treat Options Gastroenterol       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.